INCY vs. ILMN
INCY (Incyte Corporation) and ILMN (Illumina, Inc.) are both stocks. Both are in the Healthcare sector — INCY in Biotechnology, ILMN in Diagnostics & Research. Over the past 10 years, INCY returned 3.00%/yr vs 2.36%/yr for ILMN. Their 0.34 correlation means their historical movements had little consistent relationship.
Performance
INCY vs. ILMN - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, INCY achieves a 21.01% return, which is significantly lower than ILMN's 56.37% return. Over the past 10 years, INCY has outperformed ILMN with an annualized return of 3.00%, while ILMN has yielded a comparatively lower 2.36% annualized return.
INCY
- 1D
- -2.82%
- 1M
- 2.28%
- 6M
- 19.44%
- YTD
- 21.01%
- 1Y
- 58.12%
- 3Y*
- 23.35%
- 5Y*
- 9.09%
- 10Y*
- 3.00%
- ALL TIME*
- 13.53%
ILMN
- 1D
- 0.00%
- 1M
- 8.70%
- 6M
- 41.63%
- YTD
- 56.37%
- 1Y
- 116.67%
- 3Y*
- 3.66%
- 5Y*
- -15.72%
- 10Y*
- 2.36%
- ALL TIME*
- 10.71%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
ILMN Illumina, Inc. | $380.44M | $366.37M | $326.09M |
| $274.43M | $232.80M | $198.80M |
INCY vs. ILMN - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
INCY Incyte Corporation | 21.01% | 43.00% | 10.00% | -21.83% | 9.43% | -15.61% | -0.39% | 37.32% | -32.86% | -5.55% |
ILMN Illumina, Inc. | 56.37% | -1.85% | -1.34% | -31.14% | -46.85% | 2.82% | 11.53% | 10.61% | 37.27% | 70.64% |
Correlation
The correlation between INCY and ILMN is 0.25, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.25 |
Correlation (3Y) Balances recent behavior with more history. | 0.30 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.31 |
Correlation (10Y) Provides a long-term view across more market conditions. | 0.36 |
Correlation (All Time) Calculated using the full available price history since Jul 28, 2000 | 0.34 |
The correlation between INCY and ILMN shifts across timeframes, from 0.25 (1 year) to 0.36 (10 years), reflecting how their relationship changes across market environments.
Fundamentals
INCY:
$24.23B
ILMN:
$31.03B
INCY:
$7.85
ILMN:
$3.14
INCY:
15.22
ILMN:
65.26
INCY:
0.02
ILMN:
30.63
INCY:
4.22
ILMN:
7.03
INCY:
3.92
ILMN:
10.10
INCY:
$5.82B
ILMN:
$4.49B
INCY:
$5.39B
ILMN:
$3.00B
INCY:
$2.04B
ILMN:
$1.20B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
INCY vs. ILMN — Risk / Return Rank
INCY
ILMN
INCY vs. ILMN - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Incyte Corporation (INCY) and Illumina, Inc. (ILMN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| INCY | ILMN | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.30 | ||
| Sortino ratioReturn per unit of downside risk | -0.48 | ||
| Omega ratioGain probability vs. loss probability | 1.32 | 1.36 | -0.04 |
| Calmar ratioReturn relative to maximum drawdown | 3.27 | 3.91 | -0.64 |
| Martin ratioReturn relative to average drawdown | 7.23 | 9.85 | -2.61 |
Loading charts...
Drawdowns
INCY vs. ILMN - Drawdown Comparison
The maximum INCY drawdown since its inception was -98.54%, roughly equal to the maximum ILMN drawdown of -96.14%. Use the drawdown chart below to compare losses from any high point for INCY and ILMN.
Loading charts...
Drawdown Indicators
| INCY | ILMN | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -98.54% | -96.14% | -2.40% |
Max Drawdown (1Y)Largest decline over 1 year | -18.33% | -25.66% | +7.33% |
Max Drawdown (3Y)Largest decline over 3 years | -33.83% | -61.49% | +27.66% |
Max Drawdown (5Y)Largest decline over 5 years | -40.50% | -86.23% | +45.73% |
Max Drawdown (10Y)Largest decline over 10 years | -66.47% | -86.23% | +19.76% |
Current DrawdownCurrent decline from peak | -21.71% | -59.83% | +38.12% |
Average DrawdownAverage peak-to-trough decline | -59.75% | -40.52% | -19.23% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 8.26% | 10.24% | -1.98% |
Volatility
INCY vs. ILMN - Volatility Comparison
Incyte Corporation (INCY) has a higher volatility of 11.85% compared to Illumina, Inc. (ILMN) at 10.62%. This indicates that INCY's price experiences larger fluctuations and is considered to be riskier than ILMN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| INCY | ILMN | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 11.85% | 10.62% | +1.23% |
Volatility (6M)Calculated over the trailing 6-month period | 24.86% | 30.48% | -5.62% |
Volatility (1Y)Calculated over the trailing 1-year period | 33.44% | 47.88% | -14.44% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 30.10% | 46.02% | -15.92% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 34.35% | 42.22% | -7.87% |
Dividends
INCY vs. ILMN - Dividend Comparison
Neither INCY nor ILMN has paid dividends to shareholders.
Financials
INCY vs. ILMN - Financials Comparison
This section allows you to compare key financial metrics between Incyte Corporation and Illumina, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
INCY vs. ILMN - Profitability Comparison
INCY - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Incyte Corporation reported a gross profit of 1.57B and revenue of 1.67B. Therefore, the gross margin over that period was 93.7%.
ILMN - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Illumina, Inc. reported a gross profit of 770.00M and revenue of 1.16B. Therefore, the gross margin over that period was 66.4%.
INCY - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Incyte Corporation reported an operating income of 697.90M and revenue of 1.67B, resulting in an operating margin of 41.7%.
ILMN - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Illumina, Inc. reported an operating income of 245.00M and revenue of 1.16B, resulting in an operating margin of 21.1%.
INCY - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Incyte Corporation reported a net income of 585.61M and revenue of 1.67B, resulting in a net margin of 35.0%.
ILMN - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Illumina, Inc. reported a net income of -134.00M and revenue of 1.16B, resulting in a net margin of -11.6%.
Frequently Asked Questions
INCY and ILMN have a correlation of 0.25, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
INCY has higher volatility (11.85%) compared to ILMN (10.62%). In terms of maximum drawdown, INCY dropped -98.54% vs ILMN's -96.14%.
ILMN currently has the higher Sharpe Ratio (2.10 vs 1.80), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for INCY and ILMN
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer